Target intelligence / Profile preview

Ubiquitin-conjugating enzyme E2 pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

Ubiquitin-conjugating enzyme E2 pseudogene (ENSG00000225460, also referred to as LOC124902324) is a **pseudogene**, which is a nonfunctional segment of DNA that resembles functional ubiquitin-conjugating enzyme E2 genes. Pseudogenes arise by gene duplication or retrotransposition events and accumulate mutations that disable their ability to code for a functional protein[2][8][6]. Ubiquitin-conjugating enzymes (E2 enzymes) are responsible for the ubiquitination of proteins, playing a role in targeting proteins for degradation by the proteasome[1]. However, this particular locus does not produce an active enzyme or participate in the ubiquitination pathway[2][8][6]. Pseudogenes are generally not considered therapeutic targets, though some pseudogenes elsewhere in the genome have been found to carry regulatory roles via RNA-level effects, these are the exception rather than the rule and require specific evidence not provided for this locus[4][6].

Other names
LOC124902324ENSG00000225460ubiquitin-conjugating enzyme E2 pseudogene

Beyond the preview

Go deeper on Ubiquitin-conjugating enzyme E2 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin-conjugating enzyme E2 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call